Due to the unprecedented nature of the COVID-19 pandemic, anyone reporting an Adverse Event and/or a Product Complaint via phone, should you receive a network busy signal (ie: if all lines busy/engaged) please continue to try your call throughout the day. Alternatively, you may email your Adverse Event to drugsafety@propharmagroup.com OR Product Complaint to productcomplaint@propharmagroup.com, OR medical information request to MedInfo@propharmagroup.com.

NDC Change – Piperacillin and Tazobactam for Injection


Important Product Update:

Please order the new NDC, 44567-802-10, 3.375 g in a 30 mL vial.
The 3.375 g in a 20 mL vial, NDC 44567-882-10, has now been discontinued at the wholesalers.

[fancy_link link=”https://www.wgcriticalcare.com/injectable-pharmaceuticals/our-products/piperacillin-and-tazobactam-for-injection/” variation=”slategrey”]Please check the product page for more information[/fancy_link]
[one_half_last][image_frame style=”framed” height=”288″ width=”432″]https://www.wgcriticalcare.com/injectable-pharmaceuticals/wp-content/uploads/2013/07/Piperacillin-and-Tazobactam-For-Injection-3_375g-Post.jpg[/image_frame]

© 2021 WG Critical Care, LLC | A PharmaSphere Company | 120 Rte 17 N, Paramus, NJ 07652